Internet Administered CBT for Insomnia Comorbid With Chronic Pain (SoV-studien)

January 8, 2021 updated by: Bjorn Gerdle, Linkoeping University

Internet Administered CBT for Insomnia Comorbid With Chronic Pain Compared to Applied Relaxation Techniques - A Randomized Controlled Trial

Cognitive behavioural therapy (CBT), that is designed to be short, concise and user friendly is compared to applied relaxation techniques as treatment for insomnia comorbid with chronic pain. Both treatments are administered via internet and participants are randomized to ether treatment arm.

Study Overview

Detailed Description

Internet treatment with therapist support means that measurements are collected through the Internet. Participants are recruited from a specialized pain clinic for chronic pain. All patients with sleep complaints (Insomnia Severity Index > 14) at their first visit through 2016-01-01 to 2017-07-31 are asked for participation via mail. Volunteers sign informed consent and undergo a online screening. If matching the inclusion criteria, they are contacted for a telephone interview. Subjects are assessed according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criterion for insomnia disorder, M.I.N.I. (screening for psychiatric comorbidity) and the other inclusion/exclusion criteria. The treatment, that is designed to be short, concise and user friendly as it is meant to be usable as an adjunct treatment to other main interventions for chronic pain. The treatment lasts for five weeks and focuses on the most potent CBT technics for insomnia; sleep restriction and stimulus control.

Randomization is conducted by university staff not otherwise involved in this study. Participants have equal chance to be allocated to ether CBT or applied relaxation techniques (active controls). The relaxation treatment lasts for the same amount of time (five weeks) and is designed to require similar weekly effort. Both groups fill in sleep diaries every week and weekly feedback is provided by master students supervised by clinical psychologists.

The overall hypothesis is that CBT leads to greater symptom reduction (according to the Insomnia Severity Index) compared to applied relaxation techniques.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Östergötland
      • Linköping, Östergötland, Sweden, SE 58185
        • Rehabilitation medicine, IMH, Linköping University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Insomnia severity index (ISI) score > 14
  • Chronic pain

Exclusion Criteria:

  • Shift worker or employed as a driver, operator of dangerous equipment and such
  • Sleep apnea, restless legs syndrome, narcolepsy, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
  • Bipolar disorder, psychotic disorders, ongoing substance abuse
  • Having received CBT for insomnia during the latest year
  • Pregnancy
  • Severe somatic disorder (such as ongoing cancer, severe neurological condition, insufficiently treated cardiac condition)
  • Impaired movement to such a degree that going to bed or getting out of bed requires assistance
  • Not being able read or wright in Swedish
  • Not having an internet-connected computer, cellular phone or tablet

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Internet CBT for insomnia
The intervention consists of Internet-based Cognitive Behavioral Therapy for insomnia (ICBT-i) (the main components are sleep restriction and stimulus control) for five consecutive weeks.
This intervention lasts for five weeks. The intervention is internet-based and mainly consists of the most potent CBT technics i.e. sleep restriction and stimulus control. Weekly feedback is provided by master students supervised by clinical psychologists.
Active Comparator: Internet ART for insomnia
The intervention consists of internet-based applied relaxation exercises/techniques (ART) (different and commonly used) for five consecutive weeks.The acronyme for this intervention is (IART-i).
This intervention lasts for five weeks. The intervention is internet-based and consists of different common applied relaxation exercises and treatments. Weekly feedback is provided by master students supervised by clinical psychologists.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insomnia Severity Index (ISI)
Time Frame: Change from baseline insomnia severity (ISI) at 6 months
Measures degree of insomnia. Range 0-28 where a higher value indicates worse sleep.
Change from baseline insomnia severity (ISI) at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep diary
Time Frame: Daily during treatment (five weeks).
Basis for sleep latency, total sleep time, wake time after sleep onset and sleep efficiency.
Daily during treatment (five weeks).
The Karolinska Sleepiness Scale (KSS)
Time Frame: Change from baseline sleepiness (KSS) at 5 weeks
Measures sleepiness on a single item numeric rating scale. Range 1-9, where a higher value indicates more sleepiness.
Change from baseline sleepiness (KSS) at 5 weeks
Patient Health Questionnaire (PHQ-9)
Time Frame: Change from baseline health (PHQ-9) at 6 months
Measures depressive symptoms. Range 0-27, where a higher value indicates more depressive symptoms.
Change from baseline health (PHQ-9) at 6 months
Generalised Anxiety Disorder 7-item scale (GAD-7)
Time Frame: Change from baseline anxiety (GAD-7) at 6 months
Measures anxiety symptoms. Range 0-21 where a higher value indicates more anxiety.
Change from baseline anxiety (GAD-7) at 6 months
Pain intensity (NRS)
Time Frame: Change from baseline pain intensity (NRS) at 6 months
Eleven stepped numeric rating scale (NRS) for average pain last seven days. Higher values indicate higher pain intensity.
Change from baseline pain intensity (NRS) at 6 months
Pain Disability Index (PDI)
Time Frame: Change from baseline disability (PDI) at 6 months
Quantifying pain related disability. Range 0-70 where a higher value indicates more disability.
Change from baseline disability (PDI) at 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain spreading (PS)
Time Frame: Change from baseline pain spreading (PS) at 6 months
Number of anatomical regions with pain out of 36 anatomical areas.
Change from baseline pain spreading (PS) at 6 months
Negative Effects Questionnaire (NEQ)
Time Frame: at 5 weeks and at 6 months
Monitoring and Reporting Adverse and Unwanted Events (32 items). Range 0-128 where a higher value indicates more adverse events.
at 5 weeks and at 6 months
Patient Health Questionnaire (PHQ-4)
Time Frame: Change from baseline health (PHQ-4) at 5 weeks
Measures depressive symptoms and anxiety. Range 0-12 where a higher value indicates more depressive or anxiety symptoms.
Change from baseline health (PHQ-4) at 5 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Björn Gerdle, MD, PhD, Rehabilitation medicine, IMH, Linköping University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 9, 2018

Primary Completion (Actual)

May 7, 2019

Study Completion (Actual)

May 14, 2019

Study Registration Dates

First Submitted

January 24, 2018

First Submitted That Met QC Criteria

February 1, 2018

First Posted (Actual)

February 8, 2018

Study Record Updates

Last Update Posted (Actual)

January 11, 2021

Last Update Submitted That Met QC Criteria

January 8, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Internet Cognitive Behavioral Therapy for insomnia (ICBT-i)

Subscribe